Výsledky vyhledávání - "Paul J. Strasma"

Feasibility study of a prototype extended‐wear insulin infusion set in adults with type 1 diabetes

Autor: Jasmin R. Kastner, Nisha Venkatesh, Katie Brown, Douglas B. Muchmore, Elif Ekinci, Spiros Fourlanos, Jeffrey I Joseph, Miami Shafeeq, Leon Shi, Poul Strange, Paul J. Strasma, David N. O'Neal

Publikováno v: Diabetes, Obesity and Metabolism. 24:1143-1149

To assess the feasibility of a prototype insulin infusion set (IIS) for extended wear in adults with type 1 diabetes.The prototype Capillary Biomedical investigational extended-wear IIS (CBX IIS) incorporates a soft, flexible, reinforced kink-resista

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e473b3fe19db184e01b4690336636d0b
https://doi.org/10.1111/dom.14685

Zobrazit plný text záznamu

781-P: Progressive Acceleration of Insulin Exposure over Seven Days of Infusion Set Wear

Autor: TIMOTHY S. BAILEY, JASMIN R. KASTNER, POUL STRANGE, LEI SHI, KEITH A. OBERG, JEFFREY I. JOSEPH, PAUL J. STRASMA, DOUGLAS B. MUCHMORE

Publikováno v: Diabetes. 71

Insulin exposure and action are known to differ on each of 3 days of infusion set wear during CSII. We extend these observations to 1 week in a pilot phase study comparing conventional Teflon angled infusion sets to a prototype extended wear set usin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fc95d9d7e7f795623eb90281b349bf18
https://doi.org/10.2337/db22-781-p

Zobrazit plný text záznamu

In Vivo Study of the Inflammatory Tissue Response Surrounding a Novel Extended-Wear Kink-Resistant Insulin Infusion Set Prototype Compared With a Commercial Control Over Two Weeks of Wear Time

Autor: Jasmin R. Kastner, Gabriella Eisler, Marc C. Torjman, Abdurizzagh Khalf, David Diaz, Alek R. Dinesen, Channy Loeum, Paul J. Strasma, Jeffrey I Joseph

Publikováno v: Journal of Diabetes Science and Technology. :193229682210933

Background: Infusion set function remains the limiting factor of insulin pump therapy due to nonmetabolic complications. Here, we tested an investigational extended-wear infusion set prototype with a soft, angled, wire-reinforced cannula with three a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62f8e895d76e6b82e5b6a7aa9af8e6bc
https://doi.org/10.1177/19322968221093362

Zobrazit plný text záznamu

73-OR: Development of SteadiFlow Technology, an Advanced Insulin Delivery Cannula Featuring Extended Duration of Use, More Reliable Insulin Delivery, and Reduced Inflammatory Tissue Response

Autor: Abdurizzagh Khalf, Channy Loeum, Jeffrey I. Joseph, Paul J. Strasma, Marc C. Torjman, Gabriella J. Eisler

Publikováno v: Diabetes. 68

There is great clinical need for an insulin infusion set that produces reliable and consistent insulin absorption (PK) from dose to dose and functions reliably for 7 or more days. Capillary Biomedical, Inc. is developing SteadiFlow technology which f

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7fba87286bb3e475278863064cf353c9
https://doi.org/10.2337/db19-73-or

Zobrazit plný text záznamu

In vivo investigation of the tissue response to commercial Teflon insulin infusion sets in large swine for 14 days: the effect of angle of insertion on tissue histology and insulin spread within the subcutaneous tissue

Autor: Channy Loeum, Jasmin R Kastner, Marc C. Torjman, Paul J. Strasma, Abdurizzagh Khalf, Mathew L. Thakur, David Diaz, Alek R Dinesen, Gabriella J. Eisler, Jeffrey I. Joseph

Publikováno v: BMJ Open Diabetes Research & Care

ObjectiveThis study investigated the effects of the inflammatory tissue response (ITR) to an insulin infusion set (IIS) on insulin bolus spread over wear time, as well as the effect of cannula insertion angle on the ITR, bolus shape, and pump tubing

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::712b7ebb881b6e57c052c1dbb123b8f2
https://doi.org/10.1136/bmjdrc-2019-000881

Zobrazit plný text záznamu

Functionality Evaluation of Investigational Continuous Subcutaneous Insulin Infusion (CSII) Set vs. Commercially Available Sets—Assessment of 3D Volume and Surface Area over Eight Days

Autor: Jeffrey I. Joseph, Gabriella J. Eisler, David Diaz, Aleksandr R. Dinesen, Marc C. Torjman, Channy Loeum, Paul J. Strasma, Abdurizzagh Khalf

Publikováno v: Diabetes. 67

Over 1 million people with diabetes use insulin pumps and insert a new continuous subcutaneous insulin infusion (CSII) set every 2-3 days for adequate blood glucose control. Insulin absorption from the subcutaneous tissue is slow and varies over time

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1b2a2d4ef87a20ad8ffcf15f6de4e4ee
https://doi.org/10.2337/db18-980-p

Zobrazit plný text záznamu

Vascular Glucose Sensor Symposium

Autor: Paul J. Strasma, Marc C. Torjman, Jeffrey I. Joseph

Publikováno v: Journal of Diabetes Science and Technology. 9:725-738

Hyperglycemia, hypoglycemia, and glycemic variability have been associated with increased morbidity, mortality, length of stay, and cost in a variety of critical care and non–critical care patient populations in the hospital. The results from prosp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::debaf4c641a538e4470d64b48053dd45
https://doi.org/10.1177/1932296815587938

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání